EichorEICHOR
Location: Alicante Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Alicante

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
Phase N/A · Hospital General Universitario de Alicante · Spanish Oncology Genito-Urinary Group · NCT06724159
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Pfizer · NCT06758401
Effect of PRP in Donor Semen During Cryoprervation
Phase N/A · IVI Alicante · Instituto Valenciano de Infertilidad, IVI Alicante · NCT07504575
Non-Invasive Preimplantation Genetic Screening for Aneuploidies and Clinical Outcomes in Egg Donation Patients
Phase N/A · Instituto Bernabeu · Instituto Bernabeu · NCT07364526
Randomization of Single vs Multiple Arterial Grafts
NA · Hospital Univeritario Del Vinalopo · Weill Medical College of Cornell University · NCT03217006
Spanish Registry of Esophagogastric Cancer
Phase N/A · Hospital General Universitario de Alicante · Fundación Sociedad Española de Oncologia Médica · NCT04958720
Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management
Phase 2 · Hospital General Universitario Dr. Balmis · SOLTI Breast Cancer Research Group · NCT07371585
A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary
Phase N/A · Hospital General Universitario Dr. Balmis · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · NCT06686615
Body Composition and Lifestyles in Athletes With Disabilities
Phase N/A · University of Alicante · NCT07464899
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Hosp. Gral. Univ. Dr. Balmis · Janssen Research & Development, LLC · NCT07499232
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in
Phase N/A · Hospital General de Alicante;servicio de digestivo · Hoffmann-La Roche · NCT07284121
PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS
Phase 2 · Hospital General Universitario Dr. Balmis de Alicante · PhenoNet, Inc. · NCT07142291
Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy
Phase 2 · Hospital General Universitario de Alicante · Fundación GECP · NCT05398094
Prospective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer Diagnosis
NA · Grupo Español de Investigación en Diagnóstico y Tratamiento · NCT07465848
Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants
Phase N/A · Clínica Dental esteve · Aula Dental Avanzada · NCT05500755
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Phase 1/Phase 2 · Artios Pharma Ltd · NCT04657068
Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chron
Phase 2 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06865651
Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously
Phase 3 · Hospital General Universitario de Alicante · Fundación GECP · NCT06431633
Pan Tumor Rollover Study
Phase 2 · Local Institution - 0173 · Bristol-Myers Squibb · NCT03899155
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC Wi
Phase 3 · Research Site · AstraZeneca · NCT06357533
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · Hospital General Universitario Dr. Balmis-Site Number: 72400 · Sanofi · NCT07290803
POS-ARI-ER Observational Study of Acute Respiratory Infections
Phase N/A · Hospital General Universitario de Alicante · European Clinical Research Alliance for Infectious Diseases · NCT05814237
Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer
Phase 2 · Hospital General Universitario Dr. Balmis · MedSIR · NCT07195227
Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)
Phase 4 · Hospital Universitario de Fuenlabrada · NCT05250648
Thoracic Tumours Register
Phase N/A · Hospital General de Alicante · Spanish Lung Cancer Group · NCT02941458
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557
A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed No
Phase 3 · Hospital General Universitario Dr. Balmis de Alicante · ETOP IBCSG Partners Foundation · NCT06931717
"PROTECT-ICU: Impact of an Educational Intervention
NA · Carola Giménez-Esparza Vich · NCT07542613
Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both
NA · Hospital Universitario San Juan Alicante · Fundación EPIC · NCT07190690
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson'
Phase 3 · Hoffmann-La Roche · NCT07174310
Look up another city
Look up another condition